Mercy BioAnalytics, Inc.
Troy Hawkins is an accomplished director and leader in computational biology and data science, currently serving as the Director of Computational Biology & Data Science at Mercy BioAnalytics, Inc. and as Principal at Polymorphic, providing consulting services to biotech startups. Hawkins holds an adjunct assistant professor position at Indiana University School of Medicine, where research focuses on exploratory perioperative biomarkers linked to gut inflammation and the microbiome. Previously, Hawkins was the Technology Director at Hood Medicine Initiative, Inc., and Vice President of Compute & Analytics at BiomEdit, leading initiatives in microbiome discovery. With extensive experience at Elanco and Eli Lilly and Company, Hawkins has a strong background in genomic and computational sciences, supported by a Ph.D. in Molecular Biology and Bioinformatics from Purdue University.
This person is not in any offices
Mercy BioAnalytics, Inc.
Mercy BioAnalytics is a biotechnology company that aims to improve and save the lives of people through the early detection of cancer.It has developed a process that uses nano-particles that are extraordinarily abundant in blood and carry information about their parent cell – known as extracellular vesicles, or EVs – to detect stage I cancer.Paul Blavin and Joseph Sedlak founded the Natick, Massachusetts-based company in 2018.